Essential pre-conceptual measures for the female partner before commencing an in vitro fertilisation programme

Area of Science:

• Reproductive Medicine
• Obstetrics & Gynecology

Background:

• Pre-conception care is crucial for optimizing outcomes in assisted reproductive technologies like in vitro fertilization (IVF).
• Assessing rubella immunity and cervical health is vital before commencing fertility treatments.

Purpose of the Study:

• To evaluate the availability of essential pre-conception data for women undergoing IVF.
• To identify deficiencies in rubella screening and cervical smear testing.
• To assess the impact of specific advice on folic acid supplementation.

Main Methods:

• Retrospective review of medical records for 281 women entering an IVF program.
• Analysis of rubella immunity status and cervical smear history.
• Monitoring folic acid intake before and after targeted patient education.

Main Results:

• Rubella test results were available in only 9.6% of referral notes; 54% were tested, with 2% found non-immune.
• 36% of women required a cervical smear, with 6.7% having no prior test and 12.7% abnormal results.
• Folic acid uptake increased from 15% to 97% after specific pre-conception advice.

Conclusions:

• Significant gaps exist in routine pre-conception screening for IVF candidates, particularly regarding rubella immunity and cervical health.
• Proactive testing and patient education are essential to ensure safety and improve IVF program success.
• Targeted interventions can dramatically enhance adherence to vital pre-conception recommendations like folic acid intake.